Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Çankaya
Clinical trial register · Turkey

Clinical Trials in Çankaya, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Turkey and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5418 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5418
Studies in scope
all four open statuses
2461
Recruiting now
open to new participants
548
Lead sponsors
across recruiting studies
Top sites
Istanbul 1988 Ankara 1440 Izmir 568 Adana 377 Antalya 261
Narrow the registerReset
Recruitment status
Phase
Site location
Istanbul1988 Ankara1440 Izmir568 Adana377 Antalya261
All 318 locations
Target enrolment
to

Trials with a site in Çankaya

45 of 5418 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Turkey
Start
Recruiting
Takeda
Phase 3
324
Çankaya, Mersin, Istanbul
2026-09-10
Recruiting
Donor Ankle Sensorimotor Recovery After ACL Reconstruction With a Peroneus Longus Tendon Autograft
NCT07762989Anterior Cruciate Ligament Injury, Anterior Cruciate Ligament Reconstruction, Donor Site Complication
Gazi University
Observational
20
Çankaya
2026-08-22
Recruiting
Merck Sharp & Dohme LLC
Phase 3
310
Çankaya, Kartal, Adana, Ankara, Kayseri, Mersin, Rize
2026-06-18
Recruiting
Comparison of the Rhomboid Intercostal Block and Serratus Posterior Superior Intercostal Plane Block
NCT07650877Pain, Postoperative, Multimodal Analgesia, Rhomboid Intercostal Block, Serratus Posterior Superior Intercostal Plane Block
Ankara City Hospital Bilkent
Not applicable
90
Çankaya
2026-06-15
Recruiting
MAP- Versus Cardiac Index-Guided Hemodynamic Management in Whipple Surgery
NCT07603336Whipple Procedure, Intraoperative Hemodynamic Management
Ankara Etlik City Hospital
Not applicable
60
Çankaya
2026-05-27
Recruiting
Bristol-Myers Squibb
Phase 3
850
Adana, Antalya, Çankaya, Istanbul
2026-03-16
Recruiting
Bristol-Myers Squibb
Phase 3
750
Adana, Ankara, Antalya, Cordaleo, Çankaya, Istanbul, Izmir
2026-03-12
Recruiting
Janssen Research & Development, LLC
Phase 1/2
60
Ankara, Çankaya, Istanbul
2026-03-03
Recruiting
Malnutrition Screening Study
NCT07256925Malnutrition, Calorie, Sarcopenia
Abbott Nutrition
Observational
7,500
Sarıçam, Altındağ, Çankaya, Yenimahalle, Kepez, Konyaalti, Muratpaşa, Nilufer
2026-01-12
Recruiting
Zai Lab (Shanghai) Co., Ltd.
Phase 3
480
Adana, Ankara, Çankaya, Fatih, Kadıköy, Adapazarı, Istanbul
2025-11-30
Recruiting
Patients Diagnosed With Scleroderma: Physical Performance and Functionality
NCT07183072Systemic Sclerosis (SSc), Scleroderma, Scleroderma (Limited and Diffuse), Scleroderma, Localized
Hacettepe University
Observational
50
Çankaya
2025-08-04
Recruiting
Patients Diagnosed With Scleroderma and Their Chewing and Swallowing Performance
NCT07182981Systemic Sclerosis (SSc), Scleroderma, Scleroderma (Limited and Diffuse), Scleroderma, Localized
Hacettepe University
Observational
50
Çankaya
2025-08-04
Recruiting
Investigation of Catastrophizing of Pain Reported by Parents in JIA Patients
NCT07185750Juvenile Idiopathic Arthritis (JIA), Childhood Rheumatic Diseases
Hacettepe University
Observational
50
Çankaya
2025-08-04
Recruiting
Cultural Adaptation, Validity, and Reliability of the Turkish Version of The PASTUL Questionnaire
NCT07182968Systemic Sclerosis (SSc), Systemic Sclerosis (Scleroderma), Scleroderma (Limited and Diffuse), Patient Perspective
Hacettepe University
Observational
50
Çankaya
2025-08-04
Recruiting
Azafaros B.V.
Phase 3
147
Adana, Çankaya, Bornova
2025-06-30
Active, closed
Azafaros B.V.
Phase 3
75
Adana, Çankaya, Bornova
2025-06-30
Recruiting
Azafaros B.V.
Phase 3
72
Adana, Çankaya, Bornova
2025-06-30
Recruiting
AstraZeneca
Phase 3
830
Ankara, Bakırköy, Çankaya, İzmit, Küçükçekmece, Yüreğir
2025-04-10
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
270
Çankaya, Ankara, Istanbul
2025-03-25
By invitation
Postoperative USG Control and Clinical Follow-up of Massive Rotator Cuff Tendon Ruptures
NCT07004218Early Retears and Clinical Outcomes Following Surgical Repair of Massive Rotator Cuff Tears
Gazi University
Observational
40
Çankaya
2025-02-01
Recruiting
Ankara City Hospital Bilkent
Not applicable
42
Çankaya, Ankara
2025-01-01
Recruiting
Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD) and the CRY1Δ11 Variant
NCT06701396Sleep Wake Disorders, Sleep Disorders, Circadian Rhythm, Chronobiology Disorders, Gene Mutations and Other Alterations Nec
Vanda Pharmaceuticals
Phase 3
60
Çankaya
2024-10-08
Recruiting
Ankara Etlik City Hospital
Observational
80
Çankaya, Ankara
2024-06-15
Recruiting
Immunocore Ltd
Phase 3
680
Yüreğir, Çankaya, Kepez, Antalya, Şehitkamil, Bahçelievler, Bornova, Cordaleo
2024-06-05
Recruiting
AstraZeneca
Phase 3
5,250
Adana, Afyonkarahisar, Antalya, Bursa, Çanakkale, Çankaya, Isparta, Istanbul
2024-02-21
Recruiting
Study of Olverembatinib (HQP1351) in Patients With CML-CP
NCT06423911Chronic Myeloid Leukemia, CML, CML, Chronic Phase
Ascentage Pharma Group Inc.
Phase 3
333
Adapazarı, Ankara, Battalgazi, Çankaya, Istanbul, Kepez, Mezitli, Ortahisar
2024-02-05
Active, closed
REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors)
NCT05973773Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation
Taiho Oncology, Inc.
Phase 3
285
Adana, Ankara, Edirne, Etlik, Istanbul, Çankaya
2023-12-18
Recruiting
LeonaBio
Phase 3
600
Çankaya, Çapa, Kadiköy, Bornova, Konak, İzmit, Ankara, Bursa
2023-10-31
Active, closed
AstraZeneca
Phase 3
895
Ankara, Antalya, Çankaya, Diyarbakır, Fatih-Istanbul, Istanbul, Izmir, Pamukkale
2023-10-24
Recruiting
Acrotech Biopharma Inc.
Phase 3
504
Altındağ, Çankaya, Yenimahalle, Şişli, Adana, Bornova
2023-10-04
Active, closed
Bristol-Myers Squibb
Phase 3
1,230
Ankara, Çankaya, Edirne, Istanbul, Izmir, Kayseri, Yenimahalle
2023-06-22
Active, closed
Karyopharm Therapeutics Inc
Phase 3
257
Çankaya, Adana, Ankara, Istanbul
2023-04-18
Active, closed
Janssen Research & Development, LLC
Phase 1/2
57
Ankara, Çankaya
2022-12-13
Recruiting
AbbVie
Phase 3
768
Çankaya, Cordaleo, Adana, Ankara, Battalgazi/malatya, Bursa, Diyarbakır, Istanbul
2022-03-25
Active, closed
Daiichi Sankyo
Phase 3
740
Adana, Antalya, Bornova-İzmir, Çankaya, Istanbul, Seyhan /Adana
2022-03-04
Active, closed
AstraZeneca
Phase 3
791
Adapazarı, Ankara, Antalya, Çankaya, Edirne, Istanbul, Izmir, Konya
2022-02-18
Active, closed
AstraZeneca
Phase 3
454
Çankaya, Edirne, Izmir, Kadıkoy/Istanbul
2021-10-28
Active, closed
Hoffmann-La Roche
Phase 3
751
Ankara, Çankaya, Istanbul, Kocaeli, Lzmir, Mersin, Samsun, Trabzon
2021-03-24
Active, closed
Hoffmann-La Roche
Phase 3
769
Ankara, Center, Çankaya, Istanbul, Kayseri, Kocaeli, Lzmir, Mersin
2020-12-03
Recruiting
Mirati Therapeutics Inc.
Phase 2/3
626
Alanya, Altındağ, Ankara, Antalya, Atakum, Bahçelievler, Bornova, Çankaya
2020-12-02
Active, closed
Hoffmann-La Roche
Phase 3
985
Ankara, Çankaya, Istanbul, Kocaeli, Mersin, Samsun, Trabzon, Van
2020-10-26
Active, closed
Gilead Sciences
Phase 3
340
Ankara, Bornova, Çankaya, Maltepe, Topkapı
2017-12-12
Rows per page Showing 1–45 of 45
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Turkish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-turkey/city/ankaya

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Turkey and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,418 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 45 of those studies with a site in Çankaya.

How many clinical trials are recruiting in Çankaya?

30 of the 45 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 14 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Çankaya), 45 studies
PhaseStudiesRecruitingShare
Phase 3291764.4%
Observational8717.8%
Not applicable336.7%
Phase 1/2326.7%
Phase 2/3214.4%

Most active sponsors

Lead sponsors with the most studies (Çankaya)
Lead sponsorStudiesRecruiting
AstraZeneca63
Hacettepe University44
Azafaros B.V.32
Bristol-Myers Squibb32
Hoffmann-La Roche30
Ankara City Hospital Bilkent22
Ankara Etlik City Hospital22
Gazi University21
Janssen Research & Development, LLC21
Merck Sharp & Dohme LLC22
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.